Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke

NCT00147316 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Cerebral Infarction
Brain Ischemia

Interventions

DRUG: Alteplase

Sponsor

Tanabe Pharma Corporation

Collaborators

[object Object]